BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stenvinkel P, Chertow GM, Devarajan P, Levin A, Andreoli SP, Bangalore S, Warady BA. Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2. Kidney Int Rep 2021;6:1775-87. [PMID: 34307974 DOI: 10.1016/j.ekir.2021.04.023] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
Number Citing Articles
1 Speer T, Dimmeler S, Schunk SJ, Fliser D, Ridker PM. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nat Rev Nephrol 2022. [PMID: 36064794 DOI: 10.1038/s41581-022-00621-9] [Reference Citation Analysis]
2 Tanase DM, Gosav EM, Anton MI, Floria M, Seritean Isac PN, Hurjui LL, Tarniceriu CC, Costea CF, Ciocoiu M, Rezus C. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives. Biomolecules 2022;12:1227. [PMID: 36139066 DOI: 10.3390/biom12091227] [Reference Citation Analysis]
3 Afsar B, Afsar RE. Brain-derived neurotrophic factor (BDNF): a multifaceted marker in chronic kidney disease. Clin Exp Nephrol. [DOI: 10.1007/s10157-022-02268-z] [Reference Citation Analysis]
4 Lin C, Li Y, Wang Y, Chang W. Higher Neutrophil-To-Lymphocyte Ratio Was Associated with Increased Risk of Chronic Kidney Disease in Overweight/Obese but Not Normal-Weight Individuals. IJERPH 2022;19:8077. [DOI: 10.3390/ijerph19138077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Romano M, Garcia-Bournissen F, Piskin D, Rodoplu U, Piskin L, Elzagallaai AA, Tuncer T, Sezer S, Ucuncuoglu D, Honca T, Poddighe D, Yavuz I, Stenvinkel P, Yilmaz MI, Demirkaya E. Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study. Life (Basel) 2022;12:896. [PMID: 35743929 DOI: 10.3390/life12060896] [Reference Citation Analysis]
6 Mafra D, Cardozo L, Ribeiro-alves M, Bergman P, Shiels P, Stenvinkel P. Short Report: Choline plasma levels are related to Nrf2 transcriptional expression in chronic kidney disease? Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.06.008] [Reference Citation Analysis]
7 Li A, Zhao J, Mei Y, Zhou Q, Zhao M, Xu J, Ge X, Xu Q. Variability, Clearance, and Concentration of Multiple Metals and Risk of Kidney Function Abnormality: A New Integrative Metal Exposure Assessment Approach. Expo Health. [DOI: 10.1007/s12403-022-00484-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gao J, Liang Z, Zhao F, Liu X, Ma N. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy. Bioengineered 2022;13:12275-88. [DOI: 10.1080/21655979.2022.2067293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang H, He Q, Wang J, Wang Y, Xuan X, Sui M, Zhang Z, Hou L. Biomimetic Micelles to Accurately Regulate the Inflammatory Microenvironment for Glomerulonephritis Treatment. Pharmacol Res 2022;:106263. [PMID: 35597383 DOI: 10.1016/j.phrs.2022.106263] [Reference Citation Analysis]
10 Magliocca G, Mone P, Di Iorio BR, Heidland A, Marzocco S. Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation. Int J Mol Sci 2022;23:5354. [PMID: 35628164 DOI: 10.3390/ijms23105354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lousa I, Belo L, Valente MJ, Rocha S, Preguiça I, Rocha-Pereira P, Beirão I, Mira F, Alves R, Reis F, Santos-Silva A. Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline. Inflamm Res 2022. [PMID: 35471601 DOI: 10.1007/s00011-022-01574-2] [Reference Citation Analysis]
12 Wu M, Yang F, Huang D, Ye C. Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A. BMC Complement Med Ther 2022;22:110. [PMID: 35439976 DOI: 10.1186/s12906-022-03592-3] [Reference Citation Analysis]
13 Qin Z, Li H, Wang L, Geng J, Yang Q, Su B, Liao R. Systemic Immune-Inflammation Index Is Associated With Increased Urinary Albumin Excretion: A Population-Based Study. Front Immunol 2022;13:863640. [PMID: 35386695 DOI: 10.3389/fimmu.2022.863640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kim M, Jeon J. Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases. IJMS 2022;23:2846. [DOI: 10.3390/ijms23052846] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
15 Curran CS, Kopp JB. Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease. Front Pharmacol 2022;13:782199. [DOI: 10.3389/fphar.2022.782199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Aranda-rivera AK, Srivastava A, Cruz-gregorio A, Pedraza-chaverri J, Mulay SR, Scholze A. Involvement of Inflammasome Components in Kidney Disease. Antioxidants 2022;11:246. [DOI: 10.3390/antiox11020246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Yan LJ. Folic acid-induced animal model of kidney disease. Animal Model Exp Med 2021;4:329-42. [PMID: 34977484 DOI: 10.1002/ame2.12194] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
18 Mas-bargues C, Alique M, Barrús-ortiz MT, Borrás C, Rodrigues-díez R. Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome. Antioxidants 2022;11:78. [DOI: 10.3390/antiox11010078] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Mohany M, Ahmed MM, Al-Rejaie SS. Molecular Mechanistic Pathways Targeted by Natural Antioxidants in the Prevention and Treatment of Chronic Kidney Disease. Antioxidants (Basel) 2021;11:15. [PMID: 35052518 DOI: 10.3390/antiox11010015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Cirmi S, Maugeri A, Micali A, Marini HR, Puzzolo D, Santoro G, Freni J, Squadrito F, Irrera N, Pallio G, Navarra M, Minutoli L. Cadmium-Induced Kidney Injury in Mice Is Counteracted by a Flavonoid-Rich Extract of Bergamot Juice, Alone or in Association with Curcumin and Resveratrol, via the Enhancement of Different Defense Mechanisms. Biomedicines 2021;9:1797. [PMID: 34944613 DOI: 10.3390/biomedicines9121797] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
21 Martínez-Pulleiro R, García-Murias M, Fidalgo-Díaz M, García-González MÁ. Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Alport Syndrome: A Primer for Clinicians. Int J Mol Sci 2021;22:11063. [PMID: 34681722 DOI: 10.3390/ijms222011063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]